AB0400 Intravenous Golimumab Inhibits Radiographic Progression and Maintains Clinical Efficacy and Safety in Patients with Active Rheumatoid Arthritis despite Methotrexate Therapy: 2-Year Results of A Phase 3 TRIAL of Intravenous Golimumab

M.E. Weinblatt; C.O. Bingham; A.M. Mendelsohn; L. Kim; K.H. Lo; L. Noonan; D. Baker; R. Westhovens

doi:10.1136/annrheumdis-2014-eular.2049

AB0400 Intravenous Golimumab Inhibits Radiographic Progression and Maintains Clinical Efficacy and Safety in Patients with Active Rheumatoid Arthritis despite Methotrexate Therapy: 2-Year Results of A Phase 3 TRIAL of Intravenous Golimumab

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2014-eular.2049 ◽

2014 ◽

Vol 73 (Suppl 2) ◽

pp. 939.1-939

Author(s):

M.E. Weinblatt ◽

C.O. Bingham ◽

A.M. Mendelsohn ◽

L. Kim ◽

K.H. Lo ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Efficacy ◽

Active Rheumatoid Arthritis ◽

Radiographic Progression ◽

Methotrexate Therapy ◽

Efficacy And Safety ◽

Phase 3

Download Full-text

THU0218 Intravenous Golimumab Inhibits Radiographic Progression and Maintains Clinical Efficacy and Safety in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy: 1-Year Results of a Phase 3 Trial

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2013-eular.746 ◽

2013 ◽

Vol 72 (Suppl 3) ◽

pp. A238.2-A238

Author(s):

M. Weinblatt ◽

C. O. Bingham ◽

A. Mendelsohn ◽

L. Noonan ◽

S. Sheng ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Efficacy ◽

Active Rheumatoid Arthritis ◽

Radiographic Progression ◽

Methotrexate Therapy ◽

Efficacy And Safety ◽

Phase 3

Download Full-text

Efficacy and safety results from a Phase 3, randomized, placebo-controlled trial of subcutaneous golimumab in Chinese patients with active rheumatoid arthritis despite methotrexate therapy

International Journal of Rheumatic Diseases ◽

10.1111/1756-185x.12723 ◽

2015 ◽

Vol 19 (11) ◽

pp. 1143-1156 ◽

Cited By ~ 3

Author(s):

Zhanguo Li ◽

Fengchun Zhang ◽

Jonathan Kay ◽

Kaiyin Fei ◽

Chenglong Han ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Controlled Trial ◽

Methotrexate Therapy ◽

Chinese Patients ◽

Efficacy And Safety ◽

Phase 3

Download Full-text

Clinical efficacy, radiographic progression, and safety through 156 weeks of therapy with subcutaneous golimumab in combination with methotrexate in Japanese patients with active rheumatoid arthritis despite prior methotrexate therapy: final results of the randomized GO-FORTH trial

Modern Rheumatology ◽

10.3109/14397595.2015.1109762 ◽

2015 ◽

Vol 26 (4) ◽

pp. 481-490 ◽

Cited By ~ 6

Author(s):

Yoshiya Tanaka ◽

Masayoshi Harigai ◽

Tsutomu Takeuchi ◽

Hisashi Yamanaka ◽

Naoki Ishiguro ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Efficacy ◽

Active Rheumatoid Arthritis ◽

Radiographic Progression ◽

Japanese Patients ◽

Methotrexate Therapy

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727328077.793564275 ◽

2019 ◽

Author(s):

Ladislav Senolt

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group

Download Full-text

THU0609 Patient-Reported Outcomes from A Phase 3 Study of Baricitinib versus Placebo or Adalimumab in Patients with Active Rheumatoid Arthritis and An Inadequate Response To Background Methotrexate Therapy: Table 1.

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2016-eular.1239 ◽

2016 ◽

Vol 75 (Suppl 2) ◽

pp. 412.2-413 ◽

Cited By ~ 1

Author(s):

E. Keystone ◽

P. Taylor ◽

Y. Tanaka ◽

C. Gaich ◽

A.M. DeLozier ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Patient Reported Outcomes ◽

Active Rheumatoid Arthritis ◽

Methotrexate Therapy ◽

Inadequate Response ◽

Phase 3 ◽

Patient Reported

Download Full-text

SAT0202 Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy in patients with active rheumatoid arthritis in the phase 3 monarch study, including subpopulations

10.1136/annrheumdis-2017-eular.4540 ◽

2017 ◽

Author(s):

GR Burmester ◽

Y Lin ◽

EK Mangan ◽

H van Hoogstraten ◽

T Kimura ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Efficacy And Safety ◽

Phase 3

Download Full-text

The Clinical Efficacy and Safety of Subcutaneous Oral Application of Methotrexate in Patients with Active Rheumatoid Arthritis -- Results of a Randomized, Controlled, Double-Blind, Multi-Center Study

MD Conference Express ◽

10.1177/155989770600600311 ◽

2006 ◽

Vol 6 (3) ◽

pp. 16-16

Author(s):

M. Vinall ◽

J. Braun

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Efficacy ◽

Active Rheumatoid Arthritis ◽

Efficacy And Safety ◽

Double Blind ◽

Oral Application ◽

Randomized Controlled ◽

Multi Center Study ◽

Center Study

Download Full-text

216. BARICITINIB, METHOTREXATE, OR BARICITINIB PLUS METHOTREXATE IN PATIENTS WITH MODERATELY-TO-SEVERELY ACTIVE RHEUMATOID ARTHRITIS WHO HAD RECEIVED LIMITED OR NO TREATMENT WITH DMARDS: EFFICACY AND SAFETY RESULTS FROM THE 52-WEEK PHASE 3 RA-BEGIN STUDY

Rheumatology ◽

10.1093/rheumatology/kex062.217 ◽

2017 ◽

Vol 56 (suppl_2) ◽

Author(s):

Patrick Durez ◽

David Walker ◽

Piet Geusens ◽

Filip Van den Bosch ◽

Saeed Shaikh ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Efficacy And Safety ◽

Phase 3

Download Full-text

Efficacy and Safety of Baricitinib in Japanese Patients with Active Rheumatoid Arthritis Receiving Background Methotrexate Therapy: A 12-week, Double-blind, Randomized Placebo-controlled Study

The Journal of Rheumatology ◽

10.3899/jrheum.150613.c1 ◽

2016 ◽

Vol 43 (5) ◽

pp. 998-998

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Japanese Patients ◽

Methotrexate Therapy ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind

Download Full-text

FRI0169 Intravenous golimumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with results observed by 2 weeks: Results of the phase 3, multicenter, double-blind, placebo-controlled trial

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2012-eular.2626 ◽

2013 ◽

Vol 71 (Suppl 3) ◽

pp. 368.3-369

Author(s):

M.E. Weinblatt ◽

C.O. Bingham ◽

A.M. Mendelsohn ◽

L. Kim ◽

M. Mack ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Controlled Trial ◽

Methotrexate Therapy ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text